Legal Opinion from Kangda Law Firm on the 2025 Annual Shareholders' Meeting of Beijing Saisheng Pharmaceutical Co., Ltd.
Kangda Legal Opinion No. [2026] 0104
To: Beijing Saisheng Pharmaceutical Co., Ltd.
According to the Company Law of the People's Republic of China (hereinafter referred to as "Company Law"), the Rules for Shareholders' Meetings of Listed Companies (hereinafter referred to as "Rules"), the Articles of Association of Beijing Saisheng Pharmaceutical Co., Ltd. (hereinafter referred to as "Articles of Association"), and the Legal Advisory Agreement signed between Beijing Saisheng Pharmaceutical Co., Ltd. (hereinafter referred to as "Company") and Kangda Law Firm (hereinafter referred to as "Our Firm"), the lawyers of Our Firm were engaged to attend the Company's 2025 Annual Shareholders' Meeting (hereinafter referred to as "This Meeting" or "This Shareholders' Meeting") and issue this legal opinion.
To issue this legal opinion, Our Firm's lawyers hereby declare the following:
-
The legal opinions expressed by Our Firm's lawyers are based solely on facts occurring or existing as of the date of this legal opinion and are formed based on Our Firm's lawyers' understanding of relevant laws, regulations, and normative documents. In this legal opinion, Our Firm's lawyers only verify and witness the convening and holding procedures of This Meeting, the qualifications of attendees, the voting procedures, and the voting results, and do not express opinions on the content of the proposals reviewed at This Meeting or the authenticity and accuracy of the facts and data involved in the proposals.
-
Our Firm's lawyers have issued legal opinions on the authenticity and legality of This Shareholders' Meeting in accordance with the requirements of the Company Law, the Rules, and the Articles of Association. There are no false or seriously misleading statements or significant omissions in the legal opinion; otherwise, they will bear corresponding legal responsibilities.
-
Our Firm's lawyers agree to announce this legal opinion as a necessary document for This Meeting and will bear legal responsibility for the legal opinions issued by Our Firm. Our Firm's lawyers have verified all documents related to the issuance of this legal opinion and witnessed This Meeting on-site, and based on this, the legal opinions are as follows:
I. The Convening and Holding Procedures of This Meeting
(1) The Convening of This Meeting
This Meeting was convened by the Company's Board of Directors. According to the notice published on the Giant Tide Information Network (www.cninfo.com.cn), the Company's Board of Directors issued the "Notice of the 2025 Annual Shareholders' Meeting of Beijing Saisheng Pharmaceutical Co., Ltd." on March 31, 2026. Upon verification, the Company's Board of Directors notified all shareholders 20 days prior to the holding of This Shareholders' Meeting through an announcement. According to the aforementioned announcement, the Board of Directors has clearly stated the time, place, attendees, agenda items, and registration methods for This Shareholders' Meeting, and has fully disclosed the content of all proposals in accordance with the relevant provisions of the Company Law, the Rules, and the Articles of Association.
(2) The Holding of This Meeting
Our Firm's lawyers witnessed on-site that This Meeting was held on April 23, 2026, at 14:30 at No. 8, Xingsheng Street, Beijing Economic and Technological Development Zone. The time and place of the meeting comply with the notice content, and the meeting was presided over by Mr. Ma Xia, the Chairman. The online voting for This Meeting was conducted through the Shenzhen Stock Exchange trading system and the internet voting system, with specific online voting times through the Shenzhen Stock Exchange trading system being from 9:15 to 9:25, 9:30 to 11:30, and from 13:00 to 15:00 on April 23, 2026; and through the Shenzhen Stock Exchange internet system from 9:15 to 15:00 on April 23, 2026. Upon verification, Our Firm's lawyers confirmed that the time, place, and agenda items of This Meeting were consistent with the announcement content.